Antiviral Drugs Market Size, Share & Trends Report

Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Application (HIV, Hepatitis, Herpes, Influenza), By Type (Branded, Generics), By Region, And Segment Forecasts, 2021 - 2028

Report ID: GVR-1-68038-389-8
Number of Pages: 120
Format: Electronic (PDF)

Historical Range: 2017 - 2019
Industry:Healthcare

Market Segmentation

Drug Class Outlook (Revenue, USD Million, 2017 - 2028)
- DNA Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Neuraminidase Inhibitors
- Others
Type Outlook (Revenue, USD Million, 2017 - 2028)
- Branded
- Generics
Application Outlook (Revenue, USD Million, 2017 - 2028)
- HIV
- Hepatitis
- Herpes
- Influenza
- Others
Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
  - North America Antiviral Drugs Market, By Drug Class
    - DNA Polymerase Inhibitors
    - Reverse Transcriptase Inhibitors
    - Protease Inhibitors
    - Neuraminidase Inhibitors
    - Others
  - North America Antiviral Drugs Market, By Type
    - Branded
    - Generics
  - North America Antiviral Drugs Market, By Application
    - HIV
    - Hepatitis
    - Herpes
    - Influenza
    - Others
  - U.S
  - Canada
    - Canada Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Canada Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - Canada Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
- Europe
  - Europe Antiviral Drugs Market, By Drug Class
    - DNA Polymerase Inhibitors
    - Reverse Transcriptase Inhibitors
    - Protease Inhibitors
    - Neuraminidase Inhibitors
    - Others
  - Europe Antiviral Drugs Market, By Type
    - Branded
    - Generics
  - 欧洲抗病毒药物市场,通过应用程序
    - HIV
    - Hepatitis
    - Herpes
    - Influenza
    - Others
  - U.K.
    - U.K. Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - U.K. Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - U.K. Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Germany
    - Germany Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Germany Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - Germany Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - France
    - France Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - France Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - France Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Italy
    - Italy Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Italy Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - Italy Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Spain
    - Spain Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Spain Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - Spain Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
- Asia Pacific
- Latin America
  - Latin America Antiviral Drugs Market, By Drug Class
    - DNA Polymerase Inhibitors
    - Reverse Transcriptase Inhibitors
    - Protease Inhibitors
    - Neuraminidase Inhibitors
    - Others
  - Latin America Antiviral Drugs Market, By Type
    - Branded
    - Generics
  - Latin America Antiviral Drugs Market, By Application
    - HIV
    - Hepatitis
    - Herpes
    - Influenza
    - Others
  - Argentina
    - Argentina Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Argentina Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - Argentina Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Brazil
    - Brazil Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Brazil Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - Brazil Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Mexico
    - Mexico Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Mexico Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - Mexico Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Colombia
    - Colombia Antiviral Drugs Market, By Drug Class
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Colombia Antiviral Drugs Market, By Type
      - Branded
      - Generics
    - Colombia Antiviral Drugs Market, By Application
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
- Middle East & Africa

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2017 to 2028
Market estimates and forecast for product segments up to 2028
Regional market size and forecast for product segments up to 2028
Market estimates and forecast for application segments up to 2028
Regional market size and forecast for application segments up to 2028
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.